Zoetis (ZTS) Receivables - Other (2012 - 2025)

Zoetis (ZTS) has reported Receivables - Other for 14 consecutive years, with $69.0 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Receivables - Other fell 12.66% year-over-year to $69.0 million in Q4 2025; TTM through Dec 2025 was $69.0 million, a 12.66% decrease from a year earlier, with the FY2025 full-year figure at $69.0 million, down 12.66% from the prior year.
• Receivables - Other was $69.0 million for Q4 2025 at Zoetis, down from $79.0 million in the prior quarter.
• Over five years, Receivables - Other peaked at $79.0 million in Q4 2024 and troughed at $47.0 million in Q4 2021.
• A 5-year average of $64.8 million and a median of $69.0 million in 2025 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other surged 51.06% in 2022 and declined 18.31% in 2023, its largest moves.
• Over 5 years, Receivables - Other stood at $47.0 million in 2021, then jumped by 51.06% to $71.0 million in 2022, then declined by 18.31% to $58.0 million in 2023, then soared by 36.21% to $79.0 million in 2024, then fell by 12.66% to $69.0 million in 2025.
• The last three Receivables - Other figures came in at $69.0 million (Q4 2025), $79.0 million (Q4 2024), and $58.0 million (Q4 2023), per Business Quant data.